SOUTH BALDWIN REGIONAL MEDICAL CENTE — History
CCN 010083 | 3-year financial timeline | COVID resilience: 75/100
🛡️ Public data only — no PHI permitted on this instance.
$168M
Latest Revenue (FY2022)
+12.1%
Revenue CAGR (3yr)
46.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $134M | $161M | $168M | +4.5% | +12.1% |
| Operating Expenses | $79M | $92M | $90M | -1.7% | +6.9% |
| Operating Margin | 41.0% | 43.0% | 46.4% | +7.9% | +6.3% |
| Net Income | $55M | $69M | $78M | +12.7% | +19.2% |
| Licensed Beds | 112 | 112 | 112 | +0.0% | +0.0% |
| Total Patient Days | 24,532 | 28,889 | 24,427 | -15.4% | -0.2% |
| Medicare Day % | 30% | 28% | 28% | -2.8% | -4.2% |
| Medicaid Day % | 13% | 11% | 13% | +19.8% | -0.6% |
COVID Impact & Recovery
Resilience Score: 75/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +25.6% ($134M → $168M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+12.1%
This Hospital
+7.6%
State Avg
Latest Margin
46.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $185M | 49.1% |
| FY2024 (proj) | $202M | 51.8% |
| FY2025 (proj) | $220M | 54.5% |